NovAliX Joins Hands With Max Planck Institute on Cancer Pact

March 7, 2024

Roche Shares Fall After Phase 3 Trial of Breast Cancer Drug Giredestrant Misses Primary Endpoint

March 11, 2026

Gilgamesh’s Psychedelic Drug Linked to High Remission Rate in Trial

June 2, 2025

Must Read

Partner Therapeutics’ Bizengri Grabs FDA Green Light

May 14, 2026

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

May 14, 2026

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

May 14, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

Entrada Therapeutics Reports 2.36% Dystrophin Increase in Early DMD Trial Data

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Can AI Reduce Drug Development Costs Without Increasing Risk?

Top 10 Skills Every Life Sciences Professional Needs in 2026

How Are Life Sciences Companies Reducing Environmental Impact Across Supply Chains?

Editorial Team

FDA Issues Complete Response Letter for Subcutaneous Saphnelo Application

Editor Picks

NovAliX Joins Hands With Max Planck Institute on Cancer Pact

Roche Shares Fall After Phase 3 Trial of Breast Cancer Drug Giredestrant Misses Primary Endpoint

Gilgamesh’s Psychedelic Drug Linked to High Remission Rate in Trial

Must Read

Partner Therapeutics’ Bizengri Grabs FDA Green Light

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Hot Topics

About Us

Follow Us